BBlogFlow

The Trevor Project Honors Zara Larsson with 2026 Mental Health Champion of the Year Award - The Trevor Project

·Oct 9, 2026
Source: The Trevor Project
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

The Grammy-nominated global pop star is recognized for her longstanding LGBTQ+ advocacy, allyship, and commitment to championing mental health, joy, belonging, and unapologetic self-expression

October 9, 2026 – In recognition of World Mental Health Day on October 10, The Trevor Project, the leading suicide prevention and crisis intervention organization for LGBTQ+ young people, proudly honors Grammy-nominated global pop star Zara Larsson with its 2026 Mental Health Champion of the Year Award, celebrating her longstanding advocacy for LGBTQ+ people and her openness about mental health, as well as her commitment to creating spaces rooted in freedom, authenticity, and belonging.

This article is an excerpt. To read the full content, visit the original source. The Trevor Project

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Heat's Pelle Larsson: Won't return Saturday - CBS Sports

Larsson won't return to Saturday's preseason game against the Timberwolves due to an illness, Anthony Chiang of the Miami Herald reports. Larsson missed practice time and the Heat's second preseason game due to an illness, so this is a situation worth monitoring in the coming days with the start of the regular season approaching quickly. Larsson finished with 14 points (4-15 FG, 0-2 3Pt, 6-7 FT), three rebounds and five assists across 24 minutes.

CBS Sports·

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·